TMCnet News
2bPrecise Now Brings Actionable Pharmacogenomics Data to the Point of Care2bPrecise™, an EHR-agnostic, cloud-based precision medicine platform, has launched its pharmacogenomics (PGx) solution to bring critical data to the clinical workflow in real time. 2bPrecise PGx™ makes pharmacogenetic information accessible and actionable so physicians can make informed treatment decisions based on a patient's unique genetic makeup. 2bPrecise has partnered with Translational Software, Inc. (TSI (News - Alert)), a leader in the intelligent use of genomic data for clinical decision support, to leverage its knowledge-base of PGx content. The National Institutes of Health (NIH) reports that adverse drug events result in more than 770,000 injuries and deaths each year, underscoring the importance of PGx for individualizing therapy. The 2bPrecise PGx solution uniquely plugs into the EHR's native workflow and can integrate content from TSI and other knowledge sources to enable decision-making at the point of care. 2bPrecise's PGx solution is part of its larger precision medicine platform, built to capture and store genomic data from a range of sources, enabling the harmonization of clinical knowledge and genomic research to extract patient-specific insights. 2bPrecise's unique approach to clinical workflow integration and dynamic content connectivity sets it apart from others in the pharmacogenomics space and helps future-proof healthcare organizations as genomic science advances. "What's exciting about our partnership with 2bPrecise is that its technology pushes live, real-time PGx content beyond th lab, directly into the clinical setting," said Don Rule, founder and CEO of Translational Software. "PGx data is no longer limited to a static interpretation at the time of result, allowing delivery of rich genomic insights to clinicians for more precisely diagnosing and treating their patients." 2bPrecise chose to partner with TSI based on its robust knowledge-base of actively curated, evidence-based content. TSI's proprietary knowledge platform provides genotyping prompts, genomic decision support and critical alerts regarding drug efficacy, toxicity and known interactions to guide clinical decision-making and enable physicians to prescribe the safest, most effective medications in real time. Content is maintained and curated so that changes are automatically reflected in TSI's knowledge-base - vital given the rapid emergence of new PGx findings. "As medicine becomes increasingly personalized, providers are turning to pharmacogenomics as a powerful first step into precision medicine to improve treatment effectiveness," said Bob Robke, vice president of 2bPrecise. "Our 2bPrecise PGx solution changes the paradigm by focusing on the provider workflow and the delivery of knowledge to the point of care. By offering an easy-to-use solution that plugs into existing workflows with minimal effort, an organization can achieve immediate benefits that can then scale to the growing need for additional molecular decision support."
About Translational Software, Inc.
About 2bPrecise © 2017 2bPrecise, LLC and/or its affiliates. All Rights Reserved. 2bPrecise, the 2bPrecise logo, and other 2bPrecise marks are trademarks of 2bPrecise, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of 2bPrecise, LLC and/or its affiliates.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171206005174/en/ |
